Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Ritter Pharmac. Com (RTTR)

Ritter Pharmac. Com (RTTR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.4480 +0.0080 (+1.82%) 05/22/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.4480 unch (unch) -
Quote Overview for Fri, May 22nd, 2020
Day Low
0.4401
Day High
0.5399
Open 0.4600
Previous Close 0.4400 0.4400
Volume 17,888,900 17,888,900
Avg Vol 30,627,545 30,627,545
Stochastic %K 25.20% 25.20%
Weighted Alpha -11.63 -11.63
5-Day Change -0.1820 (-28.89%) -0.1820 (-28.89%)
52-Week Range 0.1500 - 1.2700 0.1500 - 1.2700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,677
  • Shares Outstanding, K 46,153
  • Annual Sales, $ 0 K
  • Annual Income, $ -10,130 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.33
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.64
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2850 +57.19%
on 04/23/20
Period Open: 0.2940
0.7900 -43.29%
on 05/18/20
+0.1540 (+52.38%)
since 04/22/20
3-Month
0.1700 +163.53%
on 03/16/20
Period Open: 0.2329
0.8600 -47.91%
on 03/02/20
+0.2151 (+92.36%)
since 02/21/20
52-Week
0.1500 +198.67%
on 12/26/19
Period Open: 0.8300
1.2700 -64.72%
on 07/02/19
-0.3820 (-46.02%)
since 05/22/19

Most Recent Stories

More News
Docbot Closes Series A Financing Led by Khosla Ventures and Appoints Andrew J. Ritter as CEO

Docbot, Inc. , an artificial intelligence (AI) technology company focusing on gastrointestinal (GI) disease, announced today the closing of a Series A round. In conjunction with the financing, the company...

RTTR : 0.4480 (+1.82%)

Business Summary

Ritter Pharmaceuticals, Inc. is involved in developing therapeutic products to treat inflammatory, gastrointestinal and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance....

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.5758
1st Resistance Point 0.5119
Last Price 0.4480
1st Support Level 0.4121
2nd Support Level 0.3762
3rd Support Level N/A

See More

52-Week High 1.2700
Fibonacci 61.8% 0.8422
Fibonacci 50% 0.7100
Fibonacci 38.2% 0.5778
Last Price 0.4480
52-Week Low 0.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro